Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assay
International Journal of Laboratory Hematology · 2023
DOI: 10.1111/ijlh.14090 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Laboratory Hematology, 2023. Verfasst von Christian Irsara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Purpura, Thrombotic Thrombocytopenic, Thrombotic Microangiopathies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Institutional Research Funding, Baxter/Sanofi.
Abstract (Originalsprache)
Introduction
The objective of the present study was to evaluate and compare the validity and utility of two fully automated ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) activity assays for clinical diagnostic decision‐making and to compare their performance.
Methods
Two automated ADAMTS13 activity assays (Werfen HemosIL® AcuStar ADAMTS13 Activity, Technoclone Technofluor ADAMTS13 Activity) were compared with a manual FRET assay (BioMedica ACTIFLUOR ADAMTS13 Activity). The following samples were used: 13 acute phase TTP (thrombotic thrombocytopenic purpura) samples from 11 different patients, one sample from a patient with congenital ADAMTS13 deficiency, 16 samples from control patients, three follow‐up samples from TTP patients in long‐term remission and one sample from a patient with stem cell transplantation related thrombotic microangiopathy (TMA). The WHO 1st International Standard for ADAMTS13 and several dilutions of normal plasma with ADAMTS13‐depleted normal plasma were also tested. Statistical analysis included descriptive statistics, sensitivity and specificity, Passing & Bablok regression and Bland–Altman plot.
Results
The quantitative comparison between the HemosIL® (x) and Technofluor (y) methods showed a strong correlation (Pearson r = 0.98, n = 49). When considering an ADAMTS13 activity of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria.
- Department of Internal Medicine IV, Nephrology and Hypertension, Innsbruck Medical University, Innsbruck, Austria.
- Department of Internal Medicine III, Nephrology and Dialysis, Academic Teaching Hospital Feldkirch, Feldkirch, Austria.
- Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Christian Irsara
Förderung
- Institutional Research Funding
- Baxter/Sanofi
Zitieren
APA
Irsara, C., Anliker, M., Egger, A. E., Harasser, L., Lhotta, K., Feistritzer, C., Griesmacher, A., & Loacker, L. (2023). Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assay. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14090
Vancouver
Irsara C, Anliker M, Egger AE, Harasser L, Lhotta K, Feistritzer C, et al. Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assay. International Journal of Laboratory Hematology. 2023. doi:10.1111/ijlh.14090
BibTeX
@article{Irsara2023,
author = {Irsara, Christian and Anliker, Markus and Egger, Alexander E and Harasser, Lukas and Lhotta, Karl and Feistritzer, Clemens and Griesmacher, Andrea and Loacker, Lorin},
title = {Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assay},
journal = {International Journal of Laboratory Hematology},
year = {2023},
doi = {10.1111/ijlh.14090}
}
EUVIMED